BioSpace News Archive

Global Isothermal Nucleic Acid Amplification Technology Market is valued at US$ 4.53 Bn in 2023, and it is expected to reach US$ 8.91 Bn by 2031, with a CAGR of 8.94% during the forecast period of 2024-2031.

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company” or “Sona”) announces further results from the triple negative breast cancer murine model portion of its current research study at Dalhousie University (the “Study”) which confirms that the previously reported tumor volume reduction was due to activation of a tumor specific systemic immune response.

According to a new report by Insight Ace Analytic, the “Microbiology Reagents Market” in terms of revenue was estimated to be worth $2.88 Bn in 2023 and is poised to reach $4.57 Bn by 2031, growing at a CAGR of 6.17% from 2024 to 2031.

Global GMP Cell Therapy Consumables Market is valued at US$ 17.98 Mn in 2023, and it is expected to reach US$ 139.19 Mn by 2031, with a CAGR of 29.3% during the forecast period of 2024-2031.

Biosenta Inc. (CSE: ZRO) (the “Company” or “Biosenta”), is pleased to announce that it has closed its private placement for gross proceeds of $600,000 (the “Offering”), as previously announced on April 19, 2024.

Immix Biopharma, Inc. (“Immix Biopharma”, “Company”, “We” or “Us”, Nasdaq:IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced that the European Commission (EC) has granted orphan drug designation to NXC-201 for the treatment of multiple myeloma.

Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (“Justera” or the “Company”) today announces the resignation of Tyler Burpee from its board for personal reasons, effective April 24, 2024.

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, such as Alzheimer’s (AD) and Parkinson’s disease (PD), today announced the data from its Phase II/III Alzheimer study of buntanetap in mild to moderate AD patients.

GenomOncology revealed an upgraded version of GO Pathology Workbench, their software platform for tertiary analysis and reporting of next generation sequencing and other molecular testing results.

The Dermatology Association of Radiation Therapy (DART) filed comments in opposition to a proposed change in Medicare coverage in seven states of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer (NMSC).